Research projects/contents

In our research group, we investigate factors that influence the disease course of pediatric inflammatory bowel disease. We focus on translational studies using blood, tissue, and stool samples from patients. Our aim is to identify predictors of prognosis, understand triggers of acute flares, and elucidate underlying pathogenic mechanisms.

Close collaborations exist with the Institute of Pathology, the Institute of Infectious Diseases, and the Institute of Laboratory Medicine. For projects around the intestinal microbiome, we joined forces with the mucosal immunology group from the Department of Biomedical Research. We have recently initiated an explanatory randomized trial with blinded outcome assessment to investigate the effects of probiotics (i.e., beneficial bacteria) not only on the composition of the microbiome, but also on metabolomic pathways and host immune function in pediatric inflammatory bowel disease. We are also actively involved in  BeBiCo, a cohort study conducting parallel microbiome analyses in mothers and their children.

In addition, we recruit patients for the pediatric SwissIBD Cohort Study, which prospectively follows pediatric patients with inflammatory bowel disease on an annual basis in whole Switzerland, as well as the Swiss AIH Cohort Study.
The PedNet Bern supports our prospective PHASE III studies with their expertise in patient centered research.